Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

被引:0
|
作者
Valérie Martinez
Thi Dieu Ngan TA
Zahra Mokhtari
Marguerite Guiguet
Patrick Miailhes
Marc-Antoine Valantin
Fréderic Charlotte
Philippe Bertheau
Jean-Michel Molina
Christine Katlama
Eric Caumes
机构
关键词
Open Access; Base Case; Business Model; Long Term Evolution; Hepatic Steatosis;
D O I
10.1186/gb-2012-13-3-123
中图分类号
学科分类号
摘要
In this paper we evaluate the economic gains of a joint deployment of femtocells and macrocells for the provision of Long Term Evolution (LTE) mobile broadband services in urban environments. Frequency bands of 2.6 GHz and 900 MHz are analyzed and different parameters related to the business model are considered for a 30% market share operator. Results show important benefits for the base case where the service is offered to fixed-broadband clients, up to 75%, for small bandwidths. It results feasible to attribute subscriber loop costs to the radio access network (RAN) costs, so that the service could be offered to non fixed-broadband clients, in both cases of closed access and open access femtocells. However, initial savings result notably reduced, up to 50% less than in the base case if closed access is adopted and up to 13% less for open access. Site reuse reduces the initial savings only in 3%.
引用
收藏
相关论文
共 50 条
  • [21] Natural history of factors influencing the severity of chronic HCV infection in HIV-HCV coinfected patients
    Roulot, Dominique
    Vallet-Pichard, Anaies
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2007, 31 (10): : 881 - 886
  • [22] Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients
    Zylberberg, H
    Benhamou, Y
    Chaix, ML
    Fontaine, H
    Rouzioux, C
    Katlama, C
    Poynard, T
    Bréchot, C
    Pol, S
    JOURNAL OF HEPATOLOGY, 2000, 32 : 178 - 178
  • [23] Occult hepatitis B in HIV-HCV coinfected patients
    Piroth, Lionel
    Lafon, Marie-Edith
    Binquet, Christine
    Bertillon, Pascale
    Gervais, Anne
    Lootvoet, Enguerrand
    Lang, Jean-Marie
    De Jaureguiberry, Jean Pierre
    Chene, Genevieve
    Leport, Catherine
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (10) : 835 - 839
  • [24] Assessing liver disease in HIV-HCV coinfected patients
    Tsochatzis, Emmanuel A.
    Castera, Laurent
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (05) : 316 - 322
  • [25] Chronic hepatitis C in HIV-HCV coinfected patients
    Gervais, A
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 : B121 - B132
  • [26] Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy
    Verucchi, G
    Calza, L
    Biagetti, C
    Attard, L
    Costigliola, P
    Manfredi, R
    Pasquinelli, G
    Chiodo, F
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (03) : 326 - 328
  • [27] Hepatic steatosis in HIV-HCV coinfection in France: Prevalence and significance compared with HCV monoinfection
    Castera, Laurent
    Loko, Marc-Arthur
    LeBail, Birgitte
    de Ledinghen, Victor
    Winnock, Maria
    Dabis, Francois
    Neau, Didier
    HEPATOLOGY, 2006, 44 (04) : 657A - 657A
  • [28] Daily interferon therapy in HIV-HCV coinfected patients: Preliminary report.
    Bruno, R
    Sacchi, P
    Debiaggi, M
    Filice, C
    Brunetti, E
    Patruno, SFA
    Valentina, C
    Zocchetti, C
    Zara, F
    Filice, G
    HEPATOLOGY, 2000, 32 (04) : 349A - 349A
  • [29] PNPLA3 polymorphism is not associated with hepatic steatosis and fibrosis progression in HIV/HCV coinfected patients
    Payer, Berit A.
    Reiberger, Thomas
    Stift, Judith
    Aichelburg, Maximilian C.
    Breitenecker, Florian
    Ferenci, Peter
    Rieger, Armin
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2012, 56 : 1004A - 1004A
  • [30] THE PREVALENCE AND IMPACT OF HEPATIC STEATOSIS ON RESPONSE TO DAA THERAPY IN HIV-HCV COINFECTION.
    Johnson, Leigh P.
    Sterling, Richard K.
    HEPATOLOGY, 2019, 70 : 964A - 965A